Published online Nov 28, 2026. doi: 10.5528/wjtm.124522
Revised: August 12, 2026
Accepted: October 10, 2026
Published online: November 28, 2026
Processing time: 140 Days and 5.4 Hours
Sickle cell disease homozygous SS (SCD-SS) is the most prevalent hemoglo
We report an 8-year-old girl with SCD-SS and a history of ischemic stroke re
The absence of secondary stroke prevention in a child with SCD-SS proved fatal. Transcranial Doppler screening and exchange transfusion therapy are potentially life-saving interventions. Expanding access to these therapies across sub-Saharan Africa is an urgent priority.
Core Tip: This case highlights the fatal consequences of absent secondary stroke prevention in a child with sickle cell disease homozygous SS (SCD-SS). An 8-year-old girl who survived an initial ischemic stroke subsequently developed a fatal hemorrhagic stroke in the setting of Plasmodium falciparum malaria, without having received secondary preventive care. In sub-Saharan Africa, limited access to transcranial Doppler screening and exchange transfusion programs continues to place children with SCD-SS at high risk of recurrent cerebrovascular events. This report underscores the urgent need to strengthen early screening and secondary stroke prevention strategies in resource-limited settings.